Global Irritable Bowel Syndrome (IBS) Therapeutics Industry

NEW YORK, Oct. 14, 2019 /PRNewswire/ -- Irritable Bowel Syndrome (IBS) Therapeutics market worldwide is projected to grow by US$4 Billion, driven by a compounded growth of 16.2%. BS-D Drug, one of the segments analyzed and sized in this study, displays the potential to grow at over 15.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.5 Billion by the year 2025, BS-D Drug will bring in healthy gains adding significant momentum to global growth.

Read the full report: https://www.reportlinker.com/p05818083/?utm_source=PRN

- Representing the developed world, the United States will maintain a 14.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$156.1 Million to the region's size and clout in the next 5 to 6 years. Over US$128.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, BS-D Drug will reach a market size of US$121.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 20.8% over the next couple of years and add approximately US$995.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Allergan PLC; Astellas Pharma, Inc.; IM HealthScience; Mallinckrodt Pharmaceuticals; Sebela Pharmaceuticals Inc.; Takeda Pharmaceutical Co., Ltd.



Read the full report: https://www.reportlinker.com/p05818083/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Irritable Bowel Syndrome (IBS) Therapeutics Competitor Market
Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Irritable Bowel Syndrome (IBS) Therapeutics Global
Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 2: Irritable Bowel Syndrome (IBS) Therapeutics Global
Retrospective Market Scenario in US$ Million by Region/Country:
2009-2017
Table 3: Irritable Bowel Syndrome (IBS) Therapeutics Market
Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS
2025
Table 4: BS-D Drug (Type) World Market by Region/Country in US$
Million: 2018 to 2025
Table 5: BS-D Drug (Type) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 6: BS-D Drug (Type) Market Share Breakdown of Worldwide
Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: IBS-C Drug (Type) Potential Growth Markets Worldwide
in US$ Million: 2018 to 2025
Table 8: IBS-C Drug (Type) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: IBS-C Drug (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Other Types (Type) Geographic Market Spread Worldwide
in US$ Million: 2018 to 2025
Table 11: Other Types (Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2009 to 2017
Table 12: Other Types (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Irritable Bowel Syndrome (IBS) Therapeutics Market Share (in
%) by Company: 2019 & 2025
Table 13: United States Irritable Bowel Syndrome (IBS)
Therapeutics Market Estimates and Projections in US$ Million by
Type: 2018 to 2025
Table 14: Irritable Bowel Syndrome (IBS) Therapeutics Market in
the United States by Type: A Historic Review in US$ Million for
2009-2017
Table 15: United States Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS
2025
CANADA
Table 16: Canadian Irritable Bowel Syndrome (IBS) Therapeutics
Market Estimates and Forecasts in US$ Million by Type: 2018 to
2025
Table 17: Canadian Irritable Bowel Syndrome (IBS) Therapeutics
Historic Market Review by Type in US$ Million: 2009-2017
Table 18: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Canada: Percentage Share Breakdown of Sales by Type for 2009,
2019, and 2025
JAPAN
Table 19: Japanese Market for Irritable Bowel Syndrome (IBS)
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Type for the Period 2018-2025
Table 20: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Japan: Historic Sales Analysis in US$ Million by Type for the
Period 2009-2017
Table 21: Japanese Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Analysis by Type: 2009 VS 2019 VS 2025
CHINA
Table 22: Chinese Irritable Bowel Syndrome (IBS) Therapeutics
Market Growth Prospects in US$ Million by Type for the Period
2018-2025
Table 23: Irritable Bowel Syndrome (IBS) Therapeutics Historic
Market Analysis in China in US$ Million by Type: 2009-2017
Table 24: Chinese Irritable Bowel Syndrome (IBS) Therapeutics
Market by Type: Percentage Breakdown of Sales for 2009, 2019,
and 2025
EUROPE
Market Facts & Figures
European Irritable Bowel Syndrome (IBS) Therapeutics Market:
Competitor Market Share Scenario (in %) for 2019 & 2025
Table 25: European Irritable Bowel Syndrome (IBS) Therapeutics
Market Demand Scenario in US$ Million by Region/Country:
2018-2025
Table 26: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Europe: A Historic Market Perspective in US$ Million by
Region/Country for the Period 2009-2017
Table 27: European Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
Table 28: European Irritable Bowel Syndrome (IBS) Therapeutics
Market Estimates and Forecasts in US$ Million by Type:
2018-2025
Table 29: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Europe in US$ Million by Type: A Historic Review for the Period
2009-2017
Table 30: European Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
FRANCE
Table 31: Irritable Bowel Syndrome (IBS) Therapeutics Market in
France by Type: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 32: French Irritable Bowel Syndrome (IBS) Therapeutics
Historic Market Scenario in US$ Million by Type: 2009-2017
Table 33: French Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Analysis by Type: 2009 VS 2019 VS 2025
GERMANY
Table 34: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Germany: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 35: German Irritable Bowel Syndrome (IBS) Therapeutics
Historic Market Analysis in US$ Million by Type: 2009-2017
Table 36: German Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
ITALY
Table 37: Italian Irritable Bowel Syndrome (IBS) Therapeutics
Market Growth Prospects in US$ Million by Type for the Period
2018-2025
Table 38: Irritable Bowel Syndrome (IBS) Therapeutics Historic
Market Analysis in Italy in US$ Million by Type: 2009-2017
Table 39: Italian Irritable Bowel Syndrome (IBS) Therapeutics
Market by Type: Percentage Breakdown of Sales for 2009, 2019,
and 2025
UNITED KINGDOM
Table 40: United Kingdom Market for Irritable Bowel Syndrome
(IBS) Therapeutics: Annual Sales Estimates and Projections in
US$ Million by Type for the Period 2018-2025
Table 41: Irritable Bowel Syndrome (IBS) Therapeutics Market in
the United Kingdom: Historic Sales Analysis in US$ Million by
Type for the Period 2009-2017
Table 42: United Kingdom Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS
2025
SPAIN
Table 43: Spanish Irritable Bowel Syndrome (IBS) Therapeutics
Market Estimates and Forecasts in US$ Million by Type: 2018 to
2025
Table 44: Spanish Irritable Bowel Syndrome (IBS) Therapeutics
Historic Market Review by Type in US$ Million: 2009-2017
Table 45: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Spain: Percentage Share Breakdown of Sales by Type for 2009,
2019, and 2025
RUSSIA
Table 46: Russian Irritable Bowel Syndrome (IBS) Therapeutics
Market Estimates and Projections in US$ Million by Type: 2018
to 2025
Table 47: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Russia by Type: A Historic Review in US$ Million for 2009-2017
Table 48: Russian Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 49: Rest of Europe Irritable Bowel Syndrome (IBS)
Therapeutics Market Estimates and Forecasts in US$ Million by
Type: 2018-2025
Table 50: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Rest of Europe in US$ Million by Type: A Historic Review for
the Period 2009-2017
Table 51: Rest of Europe Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS
2025
ASIA-PACIFIC
Table 52: Asia-Pacific Irritable Bowel Syndrome (IBS)
Therapeutics Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 53: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Asia-Pacific: Historic Market Analysis in US$ Million by
Region/Country for the Period 2009-2017
Table 54: Asia-Pacific Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Analysis by Region/Country: 2009 VS
2019 VS 2025
Table 55: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Asia-Pacific by Type: Estimates and Projections in US$ Million
for the Period 2018-2025
Table 56: Asia-Pacific Irritable Bowel Syndrome (IBS)
Therapeutics Historic Market Scenario in US$ Million by Type:
2009-2017
Table 57: Asia-Pacific Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS
2025
AUSTRALIA
Table 58: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Australia: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 59: Australian Irritable Bowel Syndrome (IBS)
Therapeutics Historic Market Analysis in US$ Million by Type:
2009-2017
Table 60: Australian Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS
2025
INDIA
Table 61: Indian Irritable Bowel Syndrome (IBS) Therapeutics
Market Estimates and Forecasts in US$ Million by Type: 2018 to
2025
Table 62: Indian Irritable Bowel Syndrome (IBS) Therapeutics
Historic Market Review by Type in US$ Million: 2009-2017
Table 63: Irritable Bowel Syndrome (IBS) Therapeutics Market in
India: Percentage Share Breakdown of Sales by Type for 2009,
2019, and 2025
SOUTH KOREA
Table 64: Irritable Bowel Syndrome (IBS) Therapeutics Market in
South Korea: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2018-2025
Table 65: South Korean Irritable Bowel Syndrome (IBS)
Therapeutics Historic Market Analysis in US$ Million by Type:
2009-2017
Table 66: Irritable Bowel Syndrome (IBS) Therapeutics Market
Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 67: Rest of Asia-Pacific Market for Irritable Bowel
Syndrome (IBS) Therapeutics: Annual Sales Estimates and
Projections in US$ Million by Type for the Period 2018-2025
Table 68: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by
Type for the Period 2009-2017
Table 69: Rest of Asia-Pacific Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS
2025
LATIN AMERICA
Table 70: Latin American Irritable Bowel Syndrome (IBS)
Therapeutics Market Trends by Region/Country in US$ Million:
2018-2025
Table 71: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Latin America in US$ Million by Region/Country: A Historic
Perspective for the Period 2009-2017
Table 72: Latin American Irritable Bowel Syndrome (IBS)
Therapeutics Market Percentage Breakdown of Sales by
Region/Country: 2009, 2019, and 2025
Table 73: Latin American Irritable Bowel Syndrome (IBS)
Therapeutics Market Growth Prospects in US$ Million by Type for
the Period 2018-2025
Table 74: Irritable Bowel Syndrome (IBS) Therapeutics Historic
Market Analysis in Latin America in US$ Million by Type:
2009-2017
Table 75: Latin American Irritable Bowel Syndrome (IBS)
Therapeutics Market by Type: Percentage Breakdown of Sales for
2009, 2019, and 2025
ARGENTINA
Table 76: Argentinean Irritable Bowel Syndrome (IBS)
Therapeutics Market Estimates and Forecasts in US$ Million by
Type: 2018-2025
Table 77: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Argentina in US$ Million by Type: A Historic Review for the
Period 2009-2017
Table 78: Argentinean Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS
2025
BRAZIL
Table 79: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Brazil by Type: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 80: Brazilian Irritable Bowel Syndrome (IBS) Therapeutics
Historic Market Scenario in US$ Million by Type: 2009-2017
Table 81: Brazilian Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Analysis by Type: 2009 VS 2019 VS 2025
MEXICO
Table 82: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Mexico: Recent Past, Current and Future Analysis in US$ Million
by Type for the Period 2018-2025
Table 83: Mexican Irritable Bowel Syndrome (IBS) Therapeutics
Historic Market Analysis in US$ Million by Type: 2009-2017
Table 84: Mexican Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 85: Rest of Latin America Irritable Bowel Syndrome (IBS)
Therapeutics Market Estimates and Projections in US$ Million by
Type: 2018 to 2025
Table 86: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Rest of Latin America by Type: A Historic Review in US$ Million
for 2009-2017
Table 87: Rest of Latin America Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS
2025
MIDDLE EAST
Table 88: The Middle East Irritable Bowel Syndrome (IBS)
Therapeutics Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 89: Irritable Bowel Syndrome (IBS) Therapeutics Market in
the Middle East by Region/Country in US$ Million: 2009-2017
Table 90: The Middle East Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Breakdown by Region/Country: 2009,
2019, and 2025
Table 91: The Middle East Irritable Bowel Syndrome (IBS)
Therapeutics Market Estimates and Forecasts in US$ Million by
Type: 2018 to 2025
Table 92: The Middle East Irritable Bowel Syndrome (IBS)
Therapeutics Historic Market by Type in US$ Million: 2009-2017
Table 93: Irritable Bowel Syndrome (IBS) Therapeutics Market in
the Middle East: Percentage Share Breakdown of Sales by Type
for 2009, 2019, and 2025
IRAN
Table 94: Iranian Market for Irritable Bowel Syndrome (IBS)
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Type for the Period 2018-2025
Table 95: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Iran: Historic Sales Analysis in US$ Million by Type for the
Period 2009-2017
Table 96: Iranian Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Analysis by Type: 2009 VS 2019 VS 2025
ISRAEL
Table 97: Israeli Irritable Bowel Syndrome (IBS) Therapeutics
Market Estimates and Forecasts in US$ Million by Type:
2018-2025
Table 98: Irritable Bowel Syndrome (IBS) Therapeutics Market in
Israel in US$ Million by Type: A Historic Review for the Period
2009-2017
Table 99: Israeli Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 100: Saudi Arabian Irritable Bowel Syndrome (IBS)
Therapeutics Market Growth Prospects in US$ Million by Type for
the Period 2018-2025
Table 101: Irritable Bowel Syndrome (IBS) Therapeutics Historic
Market Analysis in Saudi Arabia in US$ Million by Type:
2009-2017
Table 102: Saudi Arabian Irritable Bowel Syndrome (IBS)
Therapeutics Market by Type: Percentage Breakdown of Sales for
2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 103: Irritable Bowel Syndrome (IBS) Therapeutics Market
in the United Arab Emirates: Recent Past, Current and Future
Analysis in US$ Million by Type for the Period 2018-2025
Table 104: United Arab Emirates Irritable Bowel Syndrome (IBS)
Therapeutics Historic Market Analysis in US$ Million by Type:
2009-2017
Table 105: Irritable Bowel Syndrome (IBS) Therapeutics Market
Share Distribution in United Arab Emirates by Type: 2009 VS
2019 VS 2025
REST OF MIDDLE EAST
Table 106: Irritable Bowel Syndrome (IBS) Therapeutics Market
in Rest of Middle East: Recent Past, Current and Future
Analysis in US$ Million by Type for the Period 2018-2025
Table 107: Rest of Middle East Irritable Bowel Syndrome (IBS)
Therapeutics Historic Market Analysis in US$ Million by Type:
2009-2017
Table 108: Rest of Middle East Irritable Bowel Syndrome (IBS)
Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS
2025
AFRICA
Table 109: African Irritable Bowel Syndrome (IBS) Therapeutics
Market Estimates and Projections in US$ Million by Type: 2018
to 2025
Table 110: Irritable Bowel Syndrome (IBS) Therapeutics Market
in Africa by Type: A Historic Review in US$ Million for
2009-2017
Table 111: African Irritable Bowel Syndrome (IBS) Therapeutics
Market Share Breakdown by Type: 2009 VS 2019 VS 2025

IV. COMPETITION

ALLERGAN PLC
ASTELLAS PHARMA, INC.
IM HEALTHSCIENCE
SEBELA PHARMACEUTICALS INC.
TAKEDA PHARMACEUTICAL COMPANY LIMITED

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818083/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/global-irritable-bowel-syndrome-ibs-therapeutics-industry-300937942.html

SOURCE Reportlinker